There is a new controversy on whether or not to vaccinate young girls for cervical cancer — Are the drugs Gardasil and Cervarix effective and are they actually safe?
Dr. Diane Harper, lead researcher in the development of two human papilloma virus vaccines, Gardasil and Cervarix, said the controversial drugs will do little to reduce cervical cancer rates and, even though they are being recommended for girls as young as nine, there have been no efficacy trials in children under the age of 15. Dr. Harper, director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, made these remarks during an address at the 4th International Public Conference on Vaccination which took place in Reston, Virginia on Oct. 2-4.
Dr. Harper gave these interesting statistics on HPV.
Dr. Harper began her remarks by explaining that 70 percent of all HPV infections resolve themselves without treatment within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only half will develop into cervical cancer, which leaves little need for the vaccine.
She told the meeting, “even if we get the vaccine and continue PAP screening, we will not lower the rate of cervical cancer in the US. “
Dr. Harper, who also serves as a consultant to the World Health Organization, further undercut the case for mass vaccination by saying that is four out of five women with cervical cancer are in developing countries.
Merck, the manufacturer of Gardasil, studied only a small group of girls under 16 who had been vaccinated, but did not follow them long enough to conclude sufficient presence of effective HPV antibodies.
In the reported absence of hard science about vaccinating girls as young as 11 in mandated drives, there appears to be reported side effects.
Since the drugs introduction in 2006, the public has been learning many of these facts the hard way. To date, 15,037 girls have officially reported adverse side effects from Gardasil to the Vaccine Adverse Event Reporting System (VAERS). These adverse reactions include Guilliane Barre, lupus, seizures, paralysis, blood clots, brain inflammation and many others. The CDC acknowledges that there have been 44 reported deaths.
To put that into perspective:
The outspoken researcher also weighed in last month on a report published in the Journal of the American Medical Association that raised questions about the safety of the vaccine, saying bluntly: “The rate of serious adverse events is greater than the incidence rate of cervical cancer.”
What will the future hold for Gardasil and Cervarix?